The Russian telemedicine market is expected to grow to some 90 billion rubles (approximately $1.4 billion), or 2.8% of the entire healthcare market, by 2030. As new prospects have been opened by a new legal framework, leading Russian companies and investors – including Mail.Ru Group, RDIF, Sberbank, Skolkovo and Yandex, to name just a few – have launched or announced ambitious projects. However, doubts about the prospects of this new industry are often voiced. Thus, Frost & Sullivan analysts recently pointed out a range of factors that still hinder telemedicine, from physicians’ attitudes, to regulatory obstacles, to payment systems.
This last obstacle was probably the reason why Megafon.Health, a project by major mobile operator Megafon, has been suspended. Prior to that, the Erkapharm group abandoned its planned chain of telemedicine booths, a project that had been developed in partnership with Doc+, a startup supported by Yandex.
In an exchange with online publication Invest Foresight, Vladimir Gurdus, a partner of asset management company Team Drive, shared his views on the investment prospects of Russia’s healthcare market. He also provided insights about his company Doctor Ryadom, an innovation-friendly chain of private clinics.
Vladimir Gurdus: “Artificial intelligence could well become your future practitioner”Read More
